Rafferty Asset Management, LLC Keros Therapeutics, Inc. Transaction History

Rafferty Asset Management, LLC

$28.9 Billion
Q3 2024

A detailed history of Rafferty Asset Management, LLC transactions in Keros Therapeutics, Inc. stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 41,112 shares of KROS stock, worth $686,981. This represents 0.01% of its overall portfolio holdings.

Number of Shares

41,112

Previous 57,555 28.57%

Holding current value

$686,981

Previous $2.63 Million 9.24%

% of portfolio

0.01%

Previous 0.01%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$41.68 - $58.07 $685,344 - $954,845	-16,443 Reduced 28.57%	41,112 $2.39 Million
Q2 2024 Aug 13, 2024	SELL	$44.58 - $66.89 $2.76 Million - $4.14 Million	-61,956 Reduced 51.84%	57,555 $2.63 Million
Q1 2024 May 13, 2024	BUY	$41.26 - $70.48 $2.24 Million - $3.82 Million	54,230 Added 83.07%	119,511 $7.91 Million
Q4 2023 Feb 13, 2024	BUY	$27.12 - $41.05 $192,335 - $291,126	7,092 Added 12.19%	65,281 $2.6 Million
Q3 2023 Nov 13, 2023	SELL	$31.57 - $43.02 $380,955 - $519,122	-12,067 Reduced 17.18%	58,189 $1.86 Million
Q2 2023 Aug 11, 2023	BUY	$37.26 - $51.01 $269,203 - $368,547	7,225 Added 11.46%	70,256 $2.82 Million
Q1 2023 May 11, 2023	SELL	$41.44 - $59.32 $115,410 - $165,206	-2,785 Reduced 4.23%	63,031 $2.69 Million
Q4 2022 Feb 13, 2023	BUY	$39.45 - $51.77 $336,074 - $441,028	8,519 Added 14.87%	65,816 $3.16 Million
Q3 2022 Nov 14, 2022	BUY	$27.8 - $40.12 $554,220 - $799,832	19,936 Added 53.36%	57,297 $2.16 Million
Q2 2022 Aug 12, 2022	BUY	$26.03 - $67.04 $80,484 - $207,287	3,092 Added 9.02%	37,361 $1.03 Million
Q1 2022 May 13, 2022	SELL	$42.12 - $59.36 $106,816 - $150,536	-2,536 Reduced 6.89%	34,269 $1.86 Million
Q4 2021 Feb 10, 2022	BUY	$36.95 - $62.89 $460,360 - $783,546	12,459 Added 51.17%	36,805 $2.15 Million
Q3 2021 Nov 10, 2021	SELL	$29.27 - $43.71 $29,270 - $43,710	-1,000 Reduced 3.95%	24,346 $963,000
Q2 2021 Aug 10, 2021	SELL	$42.4 - $70.11 $368,244 - $608,905	-8,685 Reduced 25.52%	25,346 $1.08 Million
Q1 2021 May 10, 2021	BUY	$54.0 - $75.28 $1.67 Million - $2.33 Million	30,951 Added 1004.9%	34,031 $2.1 Million
Q4 2020 Feb 10, 2021	BUY	$36.0 - $82.74 $110,880 - $254,839	3,080 New	3,080 $217,000

Others Institutions Holding KROS

# of Institutions

174

Shares Held

30.3M

Call Options Held

76.8K

Put Options Held

View Full List

About Keros Therapeutics, Inc.

Ticker KROS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,757,000
Market Cap $430M
Description
Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...

More about KROS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.

Account

Rafferty Asset Management, LLC Keros Therapeutics, Inc. Transaction History